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Matrix-assisted laser desorption ionization ion mobility coupled to orthogonal time-of-flight
mass spectrometry (MALDI-IM-oTOF MS) is evaluated as a tool for studying non-covalent
complex (NCX) formation between peptides. The NCX formed between dynorphin 1-7 and
Mini Gastrin I is used as a model system for comparison to previous MALDI experiments
(Woods, A. S.; Huestis, M. A. J. Am. Soc. Mass Spectrom. 2001, 12, 88–96). The dynorphin
1-7/Mini Gastrin I complex is stable after more than a ms drift time through the He filled
mobility cell. Furthermore, the effects of solution pH on NCX ion signal intensity is measured
both by MALDI-IM-MS analysis and by nanoelectrospray mass spectrometry. When compared
to the previous MALDI study this work shows that all three techniques give similar results. In
addition, fragmentation can be observed from of the non-covalent complex parent ion that
occurs prior to TOF mass analysis but after mobility separation, thus providing NCX
composition information. (J Am Soc Mass Spectrom 2002, 13, 166–169) © 2002 American
Society for Mass Spectrometry
Non-covalent interactions have been studied pre-viously, most often using electrospray ioniza-tion (ESI) mass spectrometry [1]. One of the
motivations of this approach is the possibility that the
structure and conformations of the gas-phase ions could
retain clues to biological activity. However, non-cova-
lent complexes are often in the presence of interferants
(i.e., salts, detergents, or other solubilizing agents),
which suppress ESI, making MALDI a more suitable
ionization method. Many types of non-covalent com-
plexes have also been successfully analyzed with
MALDI as shown in Farmer and Caprioli’s excellent
review [2]. Furthermore, developing the ability to di-
rectly identify non-covalent complexes on a bio-surface
such as a tissue slice or a protein array depends on first
demonstrating the capability of MALDI analysis of
complexes by testing it on model systems.
A recent study of peptide-peptide interactions [3]
has demonstrated that MALDI can be used to observe
the formation of non-covalent complexes involving a
salt bridge between an acidic peptide containing two or
more adjacent Glu or Asp and a basic peptide contain-
ing two or more adjacent Arg or the Arg-Lys-Arg motif.
The guanido group of the Arg side chain has a net
positive charge that can be neutralized by removing a
proton while the carboxyl groups of Asp and Glu have
resonance structures where one pair of electrons from
each oxygen is delocalized over the  molecular orbital
system. Therefore, the proton from the Arg side chain is
attracted to the delocalized lone pair of electrons on the
Asp or Glu side chain carboxyl group [4]. These inter-
actions between very close oppositely charged groups
in peptides and proteins are known as salt bridges [5].
The detection of such complexes by MALDI is strongly
dependent on the peptide-matrix solution pH [3, 6–8].
Anfinsen [9] has shown that loss of biological function
can come about through disruption of the tertiary
structure resulting from pH, temperature, or pressure,
leading to the disruption of non-covalent bonds.
In this work the dynorphin–minigastrin complex
model system is examined with MALDI-IM-oTOF MS
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[10]. Ion mobility has been used extensively to separate
ions of small organic molecules in the gas phase on the
basis of collision cross section-to-charge ratios (/z)
[11–16]. IM/MS has been used to determine the confor-
mations of mass identified peptide and protein ions as
well to investigate the gas-phase dynamics of biological
molecules [17–20]. Recently, ESI [14, 15] and MALDI
[10] have been used in combination with IM drift cells.
At first glance, the combination of ESI and mobility
would appear to be the most suitable method for the
analysis of non-covalent complexes because of the low
amount of initial internal energy imparted to the ions.
Nevertheless, MALDI can also impart a low amount of
internal energy to desorbed molecules.
MALDI desorption into the high-pressure (5–10 torr
He) ion mobility drift cell provides a different set of
ionization conditions from ESI or high-vacuum MALDI.
For example, a comparison was recently made between
spectra from two identical peptide digest samples using
high vacuum MALDI and MALDI-IM-TOF MS [21]. A
greater percent of amino acid coverage for the peptides
investigated was observed for MALDI-IM-TOF MS
than for conventional high-vacuum MALDI-TOF. This
may imply that the presence of buffer gas increases
stabilization of ions or promotes additional ionization
pathways that are absent when ions are ejected from the
surface into vacuum. By analogy, interaction with the
He gas may stabilize weakly bonded non-covalent
complex ions that might not otherwise be observed in
conventional high vacuum spectrometers.
The dual objectives of this study are: To determine if
NCX ions can survive transit through the IM drift cell,
and to determine if non-covalent complexes acquire a
gas-phase conformation radically different from that of
corresponding constituent peptides. The analytical util-
ity of post-mobility cell fragmentation, which allows for
the unambiguous association between fragment and
precursor ions, is also discussed.
Materials and Methods
A cGMP dependent protein kinase inhibitor peptide
[RKRARKE (943.1)], dynorphin 1-7 [YGGFLRR (MW
868.20] and Mini Gastrin I [LEEEEEAYGWMDF-NH2
(MW  1646.7)] were purchased from Sigma (St. Louis,
MO). The matrix, 6-aza-2-thiothymine (ATT) was pur-
chased from Aldrich (Milwaukee, WI). The matrix was
prepared as a saturated solution in 1:1 deionized water:
ethanol. All peptides were dissolved in deionized water
to a concentration of 100 pmol/L. MALDI samples
were prepared by mixing the acidic and basic peptides
1:1:1 with ATT in deionized water or a mixture of 1:1
ethanol:water. The matrix mixture was adjusted to pH 7
with ammonium bicarbonate and to pH 3 with formic
acid. 3–5 l were deposited on the probe tip for
MALDI-IM analysis.
Electrospray mass spectra were acquired on an MDS
Sciex (Concord, Ontario, CA) QStar Pulsar hybrid
quadrupole time-of-flight mass spectrometer in nega-
tive ion mode. Peptide solutions of 25 to 50 pmol/l in
1:1 H2O:EtOH at pH 7 were electrosprayed using the
Protana (Odense, Denmark) nanoelectrospray source.
The ion spray voltage was 1200 V and no backpressure
was used to aid nebulization. The nozzle skimmer
potential was minimized (5 V) to avoid fragmentation
in that region.
The MALDI IM-TOF instrument was built in-house,
and has been described in detail previously [10, 22].
IM/MS data handling is similar to that of GC-TOF or
LC-TOF instruments. The MALDI sample is introduced
through a standard vacuum interlock into an ion mo-
bility drift cell constructed from a series of concentric
stainless steel rings (totaling 29.5 cm in length). A
nitrogen laser (VSL-337ND, Laser Science Inc., Franklin,
MA.), operated at 20 Hz, is used for MALDI ionization.
The cell is operated at 5–10 torr He with a total drift
voltage of 1500 volts (around 10 V cm1 torr1) and is
used to separate MALDI ions on the basis of their /z
in the first dimension. As separated ions exit the mo-
bility drift cell their m/z is determined by pulsing an
extraction plate, sending the sampled packet of ions to
a time-of-flight analyzer. Total flight times in the mass
spectrometer are under 20 s. A mass spectrum is
stored for a series of drift times so that a plot of ion m/z
as a function of mobility drift time can be reconstructed
from the data. Under the standard operating conditions
of the ion mobility drift tube, drift times range from
hundreds of s to several ms, and mobility resolution
(defined as the drift time divided by peak width at
half-height) of 60 is routinely achieved. The small linear
time-of-flight mass spectrometer is 20 cm in length,
capable of 400 mass resolution, and can acquire spectra
at an extraction frequency 50 KHz. All mass mobility
contour plots were produced using Transform, and
surface plots were constructed using the IDL program-
ming language, both of which are available from Re-
search Systems (Boulder, CO).
Results and Discussion
As noted in Figure 1, a near-linear relationship exists
between m/z and mobility drift time for a homologous
series of singly charged ions, allowing classes of ions
that posses different mass/mobility trends to be distin-
guishable. For example, Figure 1 contains signals that
correspond to peptide ions and C60
/C70
. The
fullerenes posses a very different homology and gas-
phase conformation than peptide ions, and are, there-
fore, easily discernable from the peptide related signals.
Moreover, within a homologous series, there are
smaller differences in mobility between conformers of
ions that can be useful for elucidation of gas-phase ion
structure when combined with computational model-
ing and collision cross-section calculations.
The pH dependence of the dynorphin/Mini Gastrin
non-covalent complex ion signal is illustrated in Figure
1a (pH 3), Figure 1b (pH 5), and Figure 1c (pH 7). The
intensity of the complex signal is decreased at pH 3
167J Am Soc Mass Spectrom 2002, 13, 166–169 IM-MALDI OF NON-COVALENT COMPLEXES
when compared to that observed at pH 5 or 7. Mini
Gastrin I dimer ions are seen at all pH values. Similar
results for the NCX were observed for a mixture of
RKRARKE and Mini Gastrin I (data not shown). The ion
signals indicate that the non-covalent complexes were
stable enough to survive a 1.4 ms transit through the
mobility cell and the o-TOF. All non-covalent com-
plexes as well as the uncomplexed peptide ions lie
along the same mobility/mass-to-charge ratio (m/z)
trend line. Thus, the ionized gas-phase noncovalent
complex shows no gross conformational changes rela-
tive to the individual constituent peptides.
Mixtures of Mini Gastrin I and basic peptides (e.g.,
dynorphin 1-7 or RKRARKE) were also examined by
electrospray MS in negative ion mode. In each case, ion
signals corresponding to the non-covalent complex be-
tween the acidic and the basic peptide were observed
but no homodimers were detected in these ESI spectra.
For example, the triply charged ion for the dynorphin
1-7–Mini Gastrin I complex is observed at pH 7 (Figure
2a).When the same mixture is acidified (pH  2), ion
signal for the complex was not observed, only the
individual peptides were detected (Figure 2b). The data
suggests that the pH of the electrospray solution, and
that of the matrix/analyte solution, determines whether
or not a non-covalent complex forms between two
peptides. Furthermore, the results from ESI and
MALDI-IM corroborate the results previously obtained
by MALDI [1].
In addition to observing changes in ion signal with
pH, ion mobility coupled to TOF MS allows for the
direct observation of peptide complex dissociation that
occurs after the drift tube and before orthogonal extrac-
tion for TOF MS analysis. Fragmentation of the NCX
after exiting the mobility cell is illustrated in Figure 3, a
zoomed view of Figure 1b. The non-covalent complex
between Mini Gastrin I and dynorphin 1-7 undergoes
fragmentation after mobility separation has taken place,
resulting in a signal corresponding to dynorphin 1-7 at
the same mobility drift time as the much larger non-
covalent complex. This fragmentation pathway was
expected, as it represents a low energy channel of
Figure 1. Contour plots of mobility drift time versus mass-to-
charge ratio for ion signals corresponding to dynorphin 1-7 (I),
Mini Gastrin I (II), the non-covalent complex between dynorphin
1-7 and Mini Gastrin I (III), and the homodimer of Mini Gastrin I
(IV) from ATT matrix at pH 3 (a), pH 5 (b), and pH 7 (c). C60 was
added as an internal calibrant.
Figure 2. Negative ion electrospray mass spectra of dynorphin
1-7 (D1-7) Mini Gastrin I (MG) and D1-7–MG complex at pH 7 (a)
and D1-7 and MG only at pH 2 (b).
Figure 3. Mobility mass contour plot of ion signals observed
from a mixture of dynorphin 1-7 and Mini Gastrin I with ATT
matrix. Post-mobility cell fragmentation is indicated by the dashed
line, and the fragment ion signal observed is correlated to the
dynorphin 1-7 signal observed at an earlier arrival time.
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dissociation for such a complex. In addition, the obser-
vation of charge retention by dynorphin 1-7 is consis-
tent with the highly basic primary structure of the
peptide.
Conclusions
At pH values of the peptide solutions of less than 3, no
ion signals for the complexes are observed by any mass
spectrometric method used. However, as the pH was
raised to 5 or 7, MALDI-IM-oTOF MS and ESI-MS could
detect ion signals corresponding to the non-covalent
complex, verifying results obtained by MALDI-TOF
MS. No signals corresponding to homodimer formation
were present in ESI spectra. However, the NCX signals
observed under any of the three ionization conditions
exhibited similar behavior as a function of solution pH.
Therefore, the three methods (MALDI-MS, MALDI-IM-
MS, and ESI-MS) give similar information about pep-
tide–peptide complex formation.
All of the contour plots of mobility drift time versus
m/z show that the individual peptides, their complex,
and homodimers exhibit the same relationship between
drift time and m/z. Thus, no large change in conforma-
tion was observed for the non-covalent complex relative
to its constituent peptides. Post-mobility cell fragmen-
tation can be observed for these complexes illustrating
the additional utility of coupling mobility drift cells to
TOF MS. The direct correlation of fragment ions with
their mobility selected precursor parent ions is espe-
cially useful for composition analysis of species, such as
non-covalent complexes.
Future work will focus on imaging bio-surfaces
within which biologically relevant non-covalent com-
plexes exist. Work presented here will form the foun-
dation for the continued development of MALDI-IM-
oTOF MS as a sensitive method for imaging such
surfaces.
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